Alger, an investment management firm, published its ‘Alger Small Cap Focus Fund’ fourth quarter 2020 investor letter – a copy of which can be downloaded.
Alger Small Cap Focus: ‘Quidel Corp. (QDEL) is Among Our Top Detractors’
Alger, an investment management firm, published its ‘Alger Small Cap Focus Fund’ fourth quarter 2020 investor letter – a copy of which can be downloaded here. In the letter, the fund highlighted their largest portfolio sector weightings, which is in the Health Care and Information Technology sector, and their comments on notable companies. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Alger Small Cap Focus Fund, in their Q4 2020 investor letter, mentioned Quidel Corporation (NASDAQ: QDEL) and emphasized their views on the company. Quidel Corporation is a California-based diagnostic healthcare products manufacturer that currently has a $5.7 billion market capitalization. Since the beginning of the year, QDEL delivered a -24.19% return, but its 12-month gains are still up by 72.02%. As of March 12, 2021, the stock closed at $136.19 per share.
Natera Inc. (NTRA), Among Alger Small Cap’s Top Contributors
Alger, an investment management firm, published its ‘Alger Small Cap Focus Fund’ fourth quarter 2020 investor letter – a copy of which can be downloaded here. In the letter, the fund highlighted their largest portfolio sector weightings, which is in the Health Care and Information Technology sector, and their comments on notable companies. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Alger Small Cap Focus Fund, in their Q4 2020 investor letter, mentioned Natera, Inc. (NASDAQ: NTRA) and emphasized their views on the company. Natera, Inc. is a California-based clinical genetic testing company that currently has an $8.9 billion market capitalization. Since the beginning of the year, NTRA delivered a 3.81% return, impressively extending its 12-month gains to 235.44%. As of March 11, 2021, the stock closed at $103.98 per share.
Alger, an investment management firm, published its Alger Small Cap Focus Fund fourth quarter 2020 investor letter – a copy of which can be downloaded.
CareDx (CDNA), A Top Contributor for Alger Small Cap Focus Fund
Alger, an investment management firm, published its ‘Alger Small Cap Focus Fund’ fourth quarter 2020 investor letter – a copy of which can be downloaded here. In the letter, the fund highlighted their largest portfolio sector weightings, which is in the Health Care and Information Technology sector, and their comments on notable companies. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Alger Small Cap Focus Fund, in their Q4 2020 investor letter, mentioned CareDx, Inc (NASDAQ: CDNA) and emphasized their views on the company. CareDx, Inc is a California-based molecular diagnostics health care company that currently has a $3.4 billion market capitalization. Since the beginning of the year, CDNA delivered a -7.63% return, but its 12-month gains are impressively up by 235.44%. As of March 11, 2021, the stock closed at $69.35 per share.